Cytokinetics (CYTK) and Bayer (BAYRY) announced they have entered into a collaboration and license agreement for the exclusive development and commercialization of aficamten in Japan for the treatment ...

LYON, France & KUMAMOTO, Japan--(BUSINESS WIRE)--Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating respiratory viruses, and KM ...

Japan is famous for doing things efficiently, if not downright bureaucratically, so it is a little surprising how inefficient booking a private guide can be. Travelers often end up juggling emails, ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Shanghai Henlius Biotech, Inc. (Headquarters: Shanghai, China, CEO: Jason Zhu, "Henlius") announced today the conclusion of an ...

(RTTNews) - Y-mAbs Therapeutics (YMAB) and Nobelpharma have entered into a license and distribution agreement for the development and commercialization in Japan of DANYELZA for the treatment of ...

HAYWARD, Calif. & TOKYO--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS) and Taiho Pharmaceutical Co., Ltd. (“Taiho”) today announced that Taiho exercised its option for quemliclustat ...

Despite the American perspective of Japan as a technologically forward-thinking nation, new types of motorized vehicles have been heavily restricted in the land of the Motocompacto. This time, ...

Japan’s conservative economy ministry has launched a new site that offers its data for download under a Creative Commons license. The Ministry of Economy, Trade and Industry’s “Open DATA METI” project ...

TOKYO & HAYWARD, Calif.--(BUSINESS WIRE)-- Taiho Pharmaceutical Co., Ltd. (“Taiho”) and Arcus Biosciences, Inc. (RCUS) (NYSE:RCUS, “Arcus”) announced that ...